Qing Xiang

1.2k total citations
38 papers, 762 citations indexed

About

Qing Xiang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qing Xiang has authored 38 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Qing Xiang's work include Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers) and RNA modifications and cancer (4 papers). Qing Xiang is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers) and RNA modifications and cancer (4 papers). Qing Xiang collaborates with scholars based in China, United States and Switzerland. Qing Xiang's co-authors include Ralph Garippa, Scott W. Lowe, Guolin Tan, James E. Han, Aaron Y. Chang, David Ulmert, Raphael Pelossof, Ron S. Gejman, Jedd D. Wolchok and Casey A. Jarvis and has published in prestigious journals such as Nature Biotechnology, Renewable and Sustainable Energy Reviews and Bioinformatics.

In The Last Decade

Qing Xiang

37 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qing Xiang China	14	365	233	114	106	99	38	762
Sicong Hou China	17	465 1.3×	164 0.7×	182 1.6×	89 0.8×	45 0.5×	31	660
Li Pan China	18	440 1.2×	260 1.1×	118 1.0×	114 1.1×	61 0.6×	40	844
Alessandro Colapietro Italy	17	370 1.0×	262 1.1×	85 0.7×	116 1.1×	76 0.8×	34	728
Tyvette S. Hilliard United States	13	365 1.0×	379 1.6×	198 1.7×	112 1.1×	70 0.7×	25	871
Federica Maccarinelli Italy	19	393 1.1×	113 0.5×	91 0.8×	124 1.2×	174 1.8×	34	1.0k
Xiaobo Cao United States	18	554 1.5×	215 0.9×	97 0.9×	85 0.8×	241 2.4×	27	861
Debottam Sinha Australia	14	426 1.2×	296 1.3×	137 1.2×	120 1.1×	104 1.1×	28	783
Dongkyoo Park United States	14	545 1.5×	287 1.2×	93 0.8×	137 1.3×	90 0.9×	19	802
Xuehai Wang China	15	378 1.0×	135 0.6×	153 1.3×	195 1.8×	127 1.3×	60	752
Anthony L. Sinn United States	14	373 1.0×	223 1.0×	139 1.2×	123 1.2×	46 0.5×	35	699

Countries citing papers authored by Qing Xiang

Since Specialization

Citations

This map shows the geographic impact of Qing Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Xiang more than expected).

Fields of papers citing papers by Qing Xiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Xiang. The network helps show where Qing Xiang may publish in the future.

Co-authorship network of co-authors of Qing Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Xiang. A scholar is included among the top collaborators of Qing Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Xiang. Qing Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Tingting, Qing Xiang, Tian Cheng, et al.. (2025). Bivalent OX40 Aptamer and CpG as Dual Agonists for Cancer Immunotherapy. ACS Applied Materials & Interfaces. 17(5). 7353–7362. 7 indexed citations

Liu, Shuang, et al.. (2025). Exploration of common molecular mechanisms of psoriatic arthritis and aging based on integrated bioinformatics and single-cell RNA-seq analysis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(4). 167730–167730. 1 indexed citations

Xiang, Qing, et al.. (2025). Therapeutic Potential of Probiotics in Metabolic Dysfunction-Associated Steatohepatitis: A Comprehensive Review. Microorganisms. 13(8). 1894–1894.

Wang, Tiansheng, Guolin Tan, Ming Jiang, et al.. (2024). SIRT5 inhibits glycolysis and nasal type extranodal NK/T cell lymphoma cell proliferation by catalyzing the desuccinylation of glucose-6-phosphate isomerase. Translational Oncology. 51. 102215–102215. 1 indexed citations

Conti, Brooke A., Qing Xiang, Thomas J. McLellan, et al.. (2024). N6-methyladenosine in DNA promotes genome stability. eLife. 13. 1 indexed citations

Liu, Mingchun, Qing Xiang, Yu‐Han Huang, et al.. (2024). Rational Design of Untranslated Regions to Enhance Gene Expression. Journal of Molecular Biology. 436(22). 168804–168804. 5 indexed citations

Wen, Jennifer, Liang Xue, Qing Xiang, et al.. (2023). Regulated dynamic subcellular GLUT4 localization revealed by proximal proteome mapping in human muscle cells. Journal of Cell Science. 136(23). 10 indexed citations

Liang, Qi, Li Zhou, Yu Gan, et al.. (2023). Survivin degradation by bergenin overcomes pemetrexed resistance. Cellular Oncology. 46(6). 1837–1853. 8 indexed citations

Xiang, Qing, et al.. (2023). Gastrodin destabilizes survivin and overcomes pemetrexed resistance. Cellular Signalling. 110. 110851–110851. 6 indexed citations

10.

Xiang, Qing, et al.. (2023). TRAF4 regulates ubiquitination-modulated survivin turnover and confers radioresistance. International Journal of Biological Sciences. 20(1). 182–199. 5 indexed citations

11.

Pelossof, Raphael, Lauren Fairchild, Chun‐Hao Huang, et al.. (2017). Prediction of potent shRNAs with a sequential classification algorithm. Nature Biotechnology. 35(4). 350–353. 96 indexed citations

12.

Brea, Elliott J., Claire Y. Oh, Eusebio Manchado, et al.. (2016). Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells. Cancer Immunology Research. 4(11). 936–947. 128 indexed citations

13.

Olejniczak, Scott H., et al.. (2016). Coordinated Regulation of Cap-Dependent Translation and MicroRNA Function by Convergent Signaling Pathways. Molecular and Cellular Biology. 36(18). 2360–2373. 10 indexed citations

14.

Qian, Yimin, David Bolin, Karin Conde‐Knape, et al.. (2013). Design and synthesis of 2-N-substituted indazolone derivatives as non-carboxylic acid glycogen synthase activators. Bioorganic & Medicinal Chemistry Letters. 23(10). 2936–2940. 30 indexed citations

15.

Chen, Yi, Zhi Chen, Romyr Dominique, et al.. (2013). Pyrido[2,3-d]pyrimidines: Discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(24). 6610–6615. 48 indexed citations

16.

Daouti, Sherif, Huisheng Wang, Wenhui Li, et al.. (2009). Characterization of a Novel Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor with a Unique Mechanism of Action for Cancer Therapy. Cancer Research. 69(5). 1924–1932. 25 indexed citations

17.

Wang, Qing, et al.. (2009). Effect of Yikun Neiyi Wan on the Expression of Aromatase P450, COX-2, and ER Related Receptor in Endometrial Cells in Vitro from Patients with Endometriosis. Journal of Traditional Chinese Medicine. 29(4). 296–300. 8 indexed citations

18.

He, Guifang, et al.. (2008). [Apoptosis-inducing effect of 5-aminolevulinic acid-mediated photodynamic therapy (5-ALA-PDT) on cervical cancer cell lines].. PubMed. 27(9). 897–904. 6 indexed citations

19.

Sidduri, Achyutharao, Christophe Michoud, Nicole M. Jackson, et al.. (2007). Synthesis and activity of quinolinyl-methylene-thiazolinones as potent and selective cyclin-dependent kinase 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(8). 2134–2138. 50 indexed citations

20.

Xiang, Qing, et al.. (2003). [Apoptotic induction of human lung carcinoma A549 cells by DFMO through Fas/FasL pathway].. PubMed. 22(12). 1260–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact